IL18 and psoriasis: According to our knowledge, this is the first study to demonstrate higher levels of IL-18 and lower levels of sE-selectin in the GCF in psoriatic patients compared to systemically healthy controls, thereby suggesting these proteins could be promising biomarkers for future evaluations and participate in the pathogenesis of psoriasis.